Retrovirus Models of Lymphocyte Transformation and Disease- Competing Supplement
淋巴细胞转化和疾病竞争补充剂的逆转录病毒模型
基本信息
- 批准号:7016237
- 负责人:
- 金额:$ 4.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-04-21 至 2008-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The study of regulatory and accessory proteins and virus encoded enzymes of complex retroviruses such as human T-lymphotropic virus type 1 (HTLV-1) and human immunodeficiency virus (HIV) have provided fundamental knowledge to define mechanisms of viral-induced transformation and basic paradigms of cell biology. The Program Project Grant (PPG) application is focused on using retrovirus models to elucidate basic cellular mechanism governing transcriptional regulation of lymphocytes. This understanding will lead to new insights into the interface between pathogenic mechanisms of the virus during its replication and therapeutic modalities against retroviral-induced cancer. Each project will significantly expand ongoing collaborative efforts between the PPG laboratories. Project #1 is seeking to understand the essential role of p12 and p30 in transcriptional regulation in T-lymphocytes and in the establishment of HTLV-1 infection in vivo. Project #2 will extend the fundamental knowledge that defines the role of phosphorylation in HTLV Rex and thereby learn how this viral protein can be used to study mRNA transport in T-lymphocytes. Project #3 will test post-transcriptional control of retrovirus cell interaction through the use of novel control elements and retroviral vectors. Project #4 defines the role and regulation of parathyroid hormone-related protein in ATL and its associated paraneoplastic syndrome, humoral hypercalcemia of malignancy in humans and animals models. Project #5 continues the productive collaboration between The Ohio State University and Washington University, St. Louis to determine the role of the regulatory protein Tax in lymphocyte proliferation and virus-associated disease. Three interactive Cores support the PPG: Administration/Biostatistics, Imaging and Animal Models. The overall goal of the PPG is to use retrovirus models to define important mechanisms that determine lymphocyte proliferation and associated disease, as well as to test innovative modalities to ablate the effects of retroviral carcinogenesis.
描述(由申请人提供):对复杂逆转录病毒(如人嗜T淋巴细胞病毒1型(HTLV-1)和人免疫缺陷病毒(HIV))的调节和辅助蛋白以及病毒编码酶的研究为定义病毒诱导转化的机制和细胞生物学的基本范式提供了基础知识。计划项目资助(PPG)的应用重点是使用逆转录病毒模型来阐明淋巴细胞转录调控的基本细胞机制。这一认识将导致新的见解之间的接口病毒的致病机制在其复制和治疗方式对逆转录病毒引起的癌症。每个项目都将大大扩展PPG实验室之间正在进行的合作。项目#1试图了解p12和p30在T淋巴细胞转录调控和体内HTLV-1感染建立中的重要作用。项目#2将扩展定义HTLV雷克斯中磷酸化作用的基础知识,从而了解这种病毒蛋白如何用于研究T淋巴细胞中的mRNA转运。项目#3将通过使用新型控制元件和逆转录病毒载体来测试逆转录病毒细胞相互作用的转录后控制。项目#4定义了甲状旁腺相关蛋白在人类和动物模型中ATL及其相关副肿瘤综合征、恶性肿瘤体液性高钙血症中的作用和调节。项目#5继续俄亥俄州州立大学和华盛顿大学圣路易斯分校之间的富有成效的合作,以确定调节蛋白Tax在淋巴细胞增殖和病毒相关疾病中的作用。三个交互式核心支持PPG:管理/生物统计学、成像和动物模型。PPG的总体目标是使用逆转录病毒模型来定义决定淋巴细胞增殖和相关疾病的重要机制,以及测试消除逆转录病毒致癌作用的创新模式。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL D. LAIRMORE其他文献
MICHAEL D. LAIRMORE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL D. LAIRMORE', 18)}}的其他基金
Retrovirus Models of Lymphocyte Transformation and Disease
淋巴细胞转化和疾病的逆转录病毒模型
- 批准号:
7937326 - 财政年份:2009
- 资助金额:
$ 4.95万 - 项目类别:
Mechanisms of HTLV-1 p30 in Transcription and DMA Repair
HTLV-1 p30 转录和 DMA 修复机制
- 批准号:
7383661 - 财政年份:2003
- 资助金额:
$ 4.95万 - 项目类别:
Core A: Administration/Budgeting/Operations and Biostatistics & Data Integration
核心 A:管理/预算/运营和生物统计学
- 批准号:
8376230 - 财政年份:2003
- 资助金额:
$ 4.95万 - 项目类别:
Retrovirus Models of Lymphocyte Transformation/Disease
淋巴细胞转化/疾病的逆转录病毒模型
- 批准号:
6740097 - 财政年份:2003
- 资助金额:
$ 4.95万 - 项目类别:
Retrovirus Models of Lymphocyte Transformation/Disease
淋巴细胞转化/疾病的逆转录病毒模型
- 批准号:
7458547 - 财政年份:2003
- 资助金额:
$ 4.95万 - 项目类别:
Retrovirus Models of Lymphocyte Transformation/Disease
淋巴细胞转化/疾病的逆转录病毒模型
- 批准号:
7059991 - 财政年份:2003
- 资助金额:
$ 4.95万 - 项目类别:
Mechanisms of HTLV-1 p30 in Transcription and DMA Repair
HTLV-1 p30 转录和 DMA 修复机制
- 批准号:
8079527 - 财政年份:2003
- 资助金额:
$ 4.95万 - 项目类别:
Retrovirus Models of Lymphocyte Transformation/Disease
淋巴细胞转化/疾病的逆转录病毒模型
- 批准号:
6889106 - 财政年份:2003
- 资助金额:
$ 4.95万 - 项目类别:
相似海外基金
Elucidation of the pathogenesis of cancer stem cell transformation and acquisition of therapeutic resistance in lung cancer via the Hedgehog signaling system
通过 Hedgehog 信号系统阐明肺癌干细胞转化和获得治疗耐药性的发病机制
- 批准号:
23K08304 - 财政年份:2023
- 资助金额:
$ 4.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Deciphering the Role of Epstein-Barr Virus Molecular Mimicry and B cell Transformation in Multiple Sclerosis
解读 Epstein-Barr 病毒分子拟态和 B 细胞转化在多发性硬化症中的作用
- 批准号:
10568864 - 财政年份:2023
- 资助金额:
$ 4.95万 - 项目类别:
Mechanism of cell transformation by aconitase
乌头酸酶转化细胞的机制
- 批准号:
494625 - 财政年份:2023
- 资助金额:
$ 4.95万 - 项目类别:
Operating Grants
A novel treatment for eosinophilic otitis media by suppression of goblet cell transformation
通过抑制杯状细胞转化治疗嗜酸性中耳炎的新方法
- 批准号:
22K09710 - 财政年份:2022
- 资助金额:
$ 4.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of the mechanism of lung cancer stem cell transformation and treatment resistance
阐明肺癌干细胞转化及治疗耐药机制
- 批准号:
21K16527 - 财政年份:2021
- 资助金额:
$ 4.95万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
proteomic analysis of smooth muscle cell transformation in obstructive lesions of pulmonary hypertension.
肺动脉高压阻塞性病变中平滑肌细胞转化的蛋白质组学分析。
- 批准号:
20K08155 - 财政年份:2020
- 资助金额:
$ 4.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Roles of the EMT transcription factors in epigenetic remodelling and myeloid cell transformation.
EMT 转录因子在表观遗传重塑和骨髓细胞转化中的作用。
- 批准号:
nhmrc : GNT1141081 - 财政年份:2018
- 资助金额:
$ 4.95万 - 项目类别:
Project Grants
Roles of the EMT transcription factors in epigenetic remodelling and myeloid cell transformation.
EMT 转录因子在表观遗传重塑和骨髓细胞转化中的作用。
- 批准号:
nhmrc : 1141081 - 财政年份:2018
- 资助金额:
$ 4.95万 - 项目类别:
Project Grants